Skip to search boxSkip to navigationSkip to main content

Rectal MRI for Cancer Staging and Surveillance

*Corresponding author for this work
  • Emory University
Scholary Output:
Contribution to journal
Review article
Peer-review

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

MRI is an integral part of the multidisciplinary treatment of rectal adenocarcinoma. Staging MRI is performed to establish TNM stage and assess for prognostic factors, including circumferential resection margin status and presence of extramural vascular invasion. The results of staging MRI determine which patients will undergo preoperative neoadjuvant chemoradiation before resection. Restaging MRI is performed to evaluate for treatment response and may identify patients with no residual visible tumor who are candidates for a “watch and wait” strategy in lieu of resection. In addition, the results of MRI in conjunction with endoscopy determine the surgical technique used to remove the tumor.

Publication Information

Output type

Scholary Output:
Contribution to journal
Review article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 537-552 (16 pages)

Journal (Volume, Issue Number)

Gastroenterology Clinics of North America (Volume 47, Issue 3)

Publication milestones

  • Accepted/In press - 01/01/2018
  • Published - 09/2018

Publication status

Published - 09/2018

ISSN

0889-8553

Publication IDs

  • Scopus: 85049342044
  • PubMed: 30115436

Publication metrics

Metrics

SciVal
citations
8
SciVal
FWCI
0.55
SciVal
Author count
3
SciVal
Paper percentile
76
Fractional count
1
Fractional count
0.33
Fractional count
2
Fractional count
0.67
Fractional count
1
Fractional count
1
Scopus
citations

PlumX, opens in new tab

Citation count
22
Captures
41